WHC is still in active development. Read this to understand our approach.
depiction of JUKMAYKVHWKRKY-UHFFFAOYSA-N.svg
tripsit

3,4-ctmp

Verificar en tripsit

psychonaut

3,4-CTMP

Verificar en psychonaut

isomerdesign

3,4-CTMP

Verificar en isomerdesign

druglab

3,4-CTMP

Verificar en druglab

drugmap

Erythro-3,4-dichloro...

Verificar en drugmap

Data

InChI: InChI=1S/C14H17Cl2NO2/c1-19-14(18)13(12-4-2-3-7-17-12)9-5-6-10(15)11(16)8-9/h5-6,8,12-13,17H,2-4,7H2,1H3

Sinónimos: 3,4-CTMP,3,4-dichloromethylphenidate,3,4-Dichloromethylphenidate,methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate,UNII-1MM9174NWD,Methyl alpha-(3,4-dichlorophenyl)-2-piperidineacetate,METHYL .ALPHA.-(3,4-DICHLOROPHENYL)-2-PIPERIDINEACETATE,Methyl (2R)-(3,4-dichlorophenyl)[(2R)-2-piperidinyl]acetate,Methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate,2-PIPERIDINEACETIC ACID, .ALPHA.-(3,4-DICHLOROPHENYL)-, METHYL ESTER,CHEMBL1179011,Methyl-(3,4-dichlorophenyl)[(2S)-2-piperidinyl]acetate,(R)-methyl 2-(3,4-dichlorophenyl)-2-((R)-piperidin-2-yl)acetate,CHEMBL537654,2-Piperidineacetic acid, alpha-(3,4-dichlorophenyl)-, methyl ester,DTXSID301029379,2-Piperidineacetic acid, alpha-(3,4-dichlorophenyl)-, methyl ester, (alphaR,2R)-,34ctmp,3,4-Ctmp,3,4-Dcmp,1MM9174NWD,(+/-)-threo-3,4-Dichloromethylphenidate,(alphaR,2R)-alpha-(3,4-Dichlorophenyl)-2-piperidineacetic acid methyl ester,F7LN3N6ZLA,210776-65-1,1364331-88-3,3,4-DCMP,3,4-DICHLOROMETHYLPHENIDATE, R,R-,UNII-F7LN3N6ZLA,BDBM50327157,1400742-68-8,methyl (2R)-2-(3,4-dichlorophenyl)-2-[(2R)-piperidin-2-yl]acetate,ZINC28645396,2-PIPERIDINEACETIC ACID, .ALPHA.-(3,4-DICHLOROPHENYL)-, METHYL ESTER, (.ALPHA.R,2R)-, Erythro-3,4-Dichloromethylphenidate HCl

Estimated data

Solubilidad: -3.551 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 77.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.